Intrauterine Contraceptive Devices (IUD) Market 2024-2028
The intrauterine contraceptive devices (IUD) market is forecasted to grow by USD 1105.8 mn during 2023-2028, accelerating at a CAGR of 4.36% during the forecast period. The report on the intrauterine contraceptive devices (IUD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing rate of unintended pregnancies and unwanted abortions, effectiveness of intrauterine devices, and high growth of E-commerce platforms.
Technavio's intrauterine contraceptive devices (IUD) market is segmented as below:
- By Type
- Hormonal intrauterine device
- Copper intrauterine device
- By End-user
- Hospitals
- Gynecology clinics
- Others
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the long-term efficacy and increased acceptance as one of the prime reasons driving the intrauterine contraceptive devices (IUD) market growth during the next few years. Also, technological advances and awareness programs by governments and competitors will lead to sizable demand in the market.
The report on the intrauterine contraceptive devices (IUD) market covers the following areas:
- Intrauterine contraceptive devices (IUD) market sizing
- Intrauterine contraceptive devices (IUD) market forecast
- Intrauterine contraceptive devices (IUD) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intrauterine contraceptive devices (IUD) market vendors that include AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd., Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc.. Also, the intrauterine contraceptive devices (IUD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.